Publication | Closed Access
The Effect of an Aromatase Inhibitor, 4-Hydroxy-4-Androstene- 3,17-Dione, On Estrogen-Dependent Processes in Reproduction and Breast Cancer<sup>1</sup><sup>1</sup>
367
Citations
0
References
1977
Year
4-Hydroxy-4-androstene- 3,17-DioneHormonal ContraceptiveReproductive HealthGynecologyFemale Reproductive FunctionReproductive BiologyMammary Gland DevelopmentOvarian AgingOvarian CancerReproductive EndocrinologyReproductive MedicineAromatase InhibitorEstradiol ConcentrationsPublic HealthRadiation OncologySteroid MetabolismHormonal ReceptorEstrogen-dependent ProcessesAromataseEndocrinologyPharmacologyOvarian HormoneEndocrine-related CancerEstrogen BiosynthesisVarious ConcentrationsBreast CancerMedicineReproductive Hormone
4-Hydroxy-f-androstene-3,17-dione (4-OH-A) when tested at various concentrations was found to inhibit markedly the conversion of 4-andorstene-3,17-dione to estrogens inhuman placental and rat ovarian microsomes. To obtain evidence that estrogen biosynthesis could also be reduced in vivo with 4-OH-A, rats were treated sc at a dose level of 50 mg/kg body weight. After 3 h the ovarian veins were cannulated and blood collected. Estradiol concentrations in the plasma were reduced by 80% compared to control values during the proestrous surge and on Day 4 of pregnancy. 4-OH-A was also found to be effective in controlling estrogen-dependent reproductive and neoplastic processes. In rats treated from Day 2-7 of pregnancy, implantation of fertilized ova was completely prevented in some rats, while in others either implantation was delayed or the development of implants was retarded. 4-OH-A treatment of rats having estrogen-dependent breast tumors induced by 7,12-dimethylbenz(a)anthracene caused 80% of the tumors to regress significantly in 4 weeks of treatment; 42% of these regressed completely.